Information Provided By: 
Fly News Breaks for November 6, 2017
SNGX
Nov 6, 2017 | 11:15 EDT
H.C. Wainwright analyst Joseph Pantginis halved his price target for Soligenix to $5.50 from $11 to reflect the recent equity raise and the pushout of his projected launch year for SGX301 from 2019 to 2020. The analyst, however, keeps a Buy rating on the shares following the company's Q3 results.
News For SNGX From the Last 2 Days
SNGX
Apr 18, 2024 | 11:18 EDT
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: Intra-Cellular Therapies... To see the rest of the story go to thefly.com. See Story Here
